Anne Nunes Anika Therapeutics, Inc. (ANIK) insider trading activity

ANIK Quotes by TradingView

Anne Nunes is SVP, Chief Operations Officer of Anika Therapeutics, Inc.. Currently has a direct ownership of 20,654 shares of ANIK, which is worth approximately $227,194. The most recent transaction as insider was on Mar 17, 2025, when has been sold 1,068 shares (Common Stock) at a price of $15.91 per share, resulting in proceeds of $16,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K
0% 3M change
86.31% 12M change
Total Value Held $227,194

Anne Nunes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2025
SELL
Payment of exercise price or tax liability
$16,991 $15.91 p/Share
1,068 Reduced 4.92%
20,654 Common Stock
Mar 17 2025
BUY
Exercise of conversion of derivative security
-
3,637 Added 14.34%
21,722 Common Stock
Mar 11 2025
SELL
Payment of exercise price or tax liability
$12,626 $16.79 p/Share
752 Reduced 3.99%
18,085 Common Stock
Mar 11 2025
BUY
Exercise of conversion of derivative security
-
2,561 Added 11.97%
18,837 Common Stock
Mar 10 2025
SELL
Payment of exercise price or tax liability
$15,938 $16.62 p/Share
959 Reduced 5.56%
16,276 Common Stock
Mar 10 2025
BUY
Exercise of conversion of derivative security
-
3,296 Added 16.05%
17,235 Common Stock
Oct 01 2024
SELL
Payment of exercise price or tax liability
$17,765 $24.27 p/Share
732 Reduced 5.15%
13,479 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
-
2,491 Added 14.91%
14,211 Common Stock
Mar 11 2024
SELL
Payment of exercise price or tax liability
$44,049 $25.61 p/Share
1,720 Reduced 13.43%
11,086 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
-
5,856 Added 33.1%
11,838 Common Stock
Oct 01 2023
SELL
Payment of exercise price or tax liability
$13,637 $18.63 p/Share
732 Reduced 12.66%
5,052 Common Stock
Oct 01 2023
BUY
Exercise of conversion of derivative security
-
2,491 Added 30.1%
5,784 Common Stock
AN

Anne Nunes

SVP, Chief Operations Officer
Bedford, MA

Track Institutional and Insider Activities on ANIK

Follow Anika Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

News

Receive news related to Anika Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANIK